WIPO Panel Accuses Celgene of Misleading Conduct in Cybersquatting Dispute
Celgene Faces Accusation of Reverse Domain Name Hijacking in CellGene.com Dispute In a notable decision highlighting the complexities of domain name disputes, Celgene Corporation (NASDAQ: CELG), a prominent biopharmaceutical company, found itself on the receiving end of accusations of reverse domain name hijacking. A three-member panel from the World Intellectual Property Organization (WIPO) concluded that … Read more